# A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

> **NCT07047820** · — · RECRUITING · sponsor: **Biogen** · enrollment: 200 (estimated)

## Conditions studied

- Depression, Postpartum

## Interventions

- **DRUG:** Zuranolone

## Key facts

- **NCT ID:** NCT07047820
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-30
- **Primary completion:** 2026-08-24
- **Final completion:** 2026-08-24
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07047820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07047820, "A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07047820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*